Pages that link to "Q4764531"
Jump to navigation
Jump to search
The following pages link to anidulafungin (Q4764531):
Displayed 50 items.
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- esophageal candidiasis (Q5398631) (← links)
- Ecalta (Q29005758) (← links)
- Anidulafungin: review of a new echinocandin antifungal agent (Q35917456) (← links)
- The echinocandins (Q36742397) (← links)
- Anidulafungin: a novel echinocandin for candida infections (Q37345790) (← links)
- Pharmacology and antifungal properties of anidulafungin, a new echinocandin (Q37359613) (← links)
- Low but sufficient anidulafungin exposure in critically ill patients (Q37544395) (← links)
- Pharmacological properties of antifungal drugs with a focus on anidulafungin (Q37624716) (← links)
- Anidulafungin, a new echinocandin: in vitro activity (Q37624719) (← links)
- Anidulafungin, a new echinocandin: effectiveness and tolerability (Q37624721) (← links)
- Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines (Q38222481) (← links)
- A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients. (Q38419657) (← links)
- Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections (Q43251797) (← links)
- Eraxis (Q47521560) (← links)
- Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis (Q61917506) (← links)
- Antimicrobial PK in Infants With Suspected or Confirmed Infection (Q61917969) (← links)
- Anidulafungin PK in Infants and Toddlers (Q63063563) (← links)
- Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients (Q63337054) (← links)
- Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations (Q63813723) (← links)
- Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia (Q63815964) (← links)
- Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease (Q63819111) (← links)
- A Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive Candidiasis (Q63830019) (← links)
- Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study (Q64045114) (← links)
- β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients (Q64047351) (← links)
- Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment (Q64229011) (← links)
- Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT) (Q64350292) (← links)
- Anidulafungin Pharmacokinetics in Intensive Care Unit Patients (Q64647760) (← links)
- Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects (Q64653061) (← links)
- Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom (Q64653067) (← links)
- Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU) (Q64657687) (← links)
- Anidulafungin in Patients With Hematologic Malignancies (Q64658197) (← links)
- Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment (Q64673385) (← links)
- Anidulafungin During Continuous Venovenous Hemofiltration (CVVHF) (Q64677863) (← links)
- Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients (Q64693757) (← links)
- An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune System (Q64697573) (← links)
- An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida (Q64697620) (← links)
- Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis (Q64714908) (← links)
- Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene) (Q64722916) (← links)
- A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects (Q65377983) (← links)
- This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis (Q65379082) (← links)
- Anidulafungin In Treatment Of Candidemia In Asian Subjects (Q65380830) (← links)
- Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis (Q65472481) (← links)
- Anidulafungin in Treating Immunocompromised Children With Neutropenia (Q66034888) (← links)
- Anidulafungin Versus Fluconazole in the Treatment of Candidemia (Q66036761) (← links)
- Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17 (Q66037094) (← links)
- The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis (Q66037095) (← links)
- The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC) (Q66038155) (← links)
- The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. (Q66038602) (← links)
- A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA). (Q66038604) (← links)